摘要
目的探讨血管性血友病因子(v WF)联合超敏C反应蛋白(hs-CRP)检测在心绞痛分型中的意义。方法将212例心绞痛患者按类型不同分为3组,稳定型心绞痛组47例,不稳定型心绞痛组132例及变异型心绞痛组33例。检测胸痛发作6h内3组患者v WF和hs-CRP水平。结果 3组患者的v WF和hs-CRP水平按从高到低顺序排列,依次为VA组、UA组和SA组,其中VA组最高,SA组最低,3组间差异均有统计学意义(P<0.01或P<0.05)。结论 v WF和hs-CRP水平的高低与心绞痛的严重程度有密切关系,v WF联合hs-CRP检测对判断心绞痛的预后有一定意义。
Objective To study the significance of detecting v WF combining with hs-CRP in angina pectoris classification. Methods 212 cases of angina pectoris patients were classified into three groups,of which 47 patients in stable angina pectoris（ SA） group,132 cases in unstable angina pectoris（ UA） group,33 cases in variant angina pectoris（ VA） group. The levels of v WF and hs-CRP were detected in 6 hours after the angina attack. Results The level list of v WF and hs-CRP from highest to lowest was VA group,UA groupand SA group; The v WF and hs-CRP level of VA group was the highest and that of SA group was the lowest; The difference among the three groups was very significant（ P〈0. 01 or P〈0. 05）. Conclusion The v WF and hs-CRP level is closely related to the severity of angina pectoris. It is useful to detecting v WF combining with hs-CRP in estimating the prognosis of angina pectoris.
出处
《临床合理用药杂志》
2015年第25期7-8,共2页
Chinese Journal of Clinical Rational Drug Use
